MGZ's Principal Activity is the medical technologies innovation and research and development; acquisition of a licence to utilise intellectual property to advance the KT009 project to treat degenerative disk disease with an injectable product; progressing and maintenance of patents and conduct of our licence arrangement and liaison with Shanghai Sol-Millennium Medical Products Co., Ltd on the Blood Collection Device and the Flash Back Needle. The licence was terminated after the end of the financial year.
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
1 Week | |
1 Month | |
2022 YTD | |
1 Year | |
vs Sector (1yr) | +8.68% |
vs ASX 200 (1yr) | +8.24% |
Date | Heading | Pages | File Size | Time |
---|---|---|---|---|
Medigard Limited (MGZ) is involved in medical technologies innovation and research and development, acquisition of a licence to utilise intellectual property to advance the KT009 project to treat degenerative disk disease with an injectable product, progressing and maintenance of patents and conduct of our licence arrangement and liaison with Shanghai Sol-Millennium MedicalProducts Co., Ltd on the Blood Collection Device and the Flash Back Needle.
Incorporated Medigard Limited was incorporated on 18 October 1999 in Queensland.
Head Office | |
Website | - |
Registry | BoardRoom |
Auditor | N/A |
Date Listed | 5 Feb 2004 |
No calendar entries available.
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
MGZ directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
The current holdings of MGZ directors.
No Substantial Shareholders for MGZ in our database.
12 month transaction history compiled from ASX announcements.
No buy transactions reported by Substantial Shareholders in the past 12 months.
12 month transaction history compiled from ASX announcements.
No sell transactions reported by Substantial Shareholders in the past 12 months.
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Year | Closing Price | Last Trade |
---|---|---|
2020 | $0.02 | 30 June |
2019 | $0.02 | 28 June |
2018 | $0.016 | 29 June |
2017 | $0.011 | 28 June |
2016 | $0.038 | 28 June |
2015 | $0.075 | 30 June |
2014 | $0.023 | 30 June |
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.